Effects of imipramine on the expression and development of morphine dependence in mice

European Journal of Pharmacology

Volumn 473, Issue 1, 2003, Pages 19-25

  Zarrindast, Mohammad Reza ^a   Torkaman Boutorabi, Anahita ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

(Mouse); Adrenoceptor agent; Imipramine; Jumping; Morphine; Naloxone

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CLONIDINE; IMIPRAMINE; MORPHINE SULFATE; NALOXONE; PHENYLEPHRINE; PRAZOSIN; SODIUM CHLORIDE; YOHIMBINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE CALCULATION; DRUG EFFECT; DRUG MECHANISM; DRUG RESPONSE; INJECTION; INTERMETHOD COMPARISON; JUMPING; LETHALITY; LOCOMOTION; MALE; MORPHINE ADDICTION; MOUSE; NONHUMAN; PREMEDICATION; PRIORITY JOURNAL; SPECIES COMPARISON; WITHDRAWAL SYNDROME;

EID: 0038487298     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)01913-7     Document Type: Article

References (30)

1. Aghajanian G.K. Tolerance of locus coeruleus neurons to morphine and suppression of withdrawal response by clonidine. Nature. 276:1978;186-188.
2. 2-adrenoceptors and opiate receptors. J. Clin. Psychiatry. 43:1982;20-24.
3. Baraldi M., Poggioli R., Santi M., Vergoni A.V., Bertolini A. Antidepressants and opiates interactions: pharmacological and biochemical evidences. Pharmacol Res. Commun. 15:1983;843-857.
4. Beani L., Tanganelli S., Antonelli T., Simonato M., Spalluto P., Tomasini C., Bianchi C. Changes in cortical acetylcholine and γ-aminobutyric acid outflow during morphine withdrawal involve alpha-1 and alpha-2 receptors. J. Pharmacol. Exp. Ther. 250:1989;682-687.
5. 1 receptor agonists attenuate the naloxone-induced jumping behaviour in morphine-dependent mice. Eur. J. Pharmacol. 162:1989;19-27.
6. Bhargava H.N. Diversity of agents that modify opioid tolerance, physical dependence, abstinence syndrome, and self-administration behaviour. Pharmacol. Rev. 46:1994;293-324.
7. Bilsky E.J., Montegut M.J., Delong C.L., Reid L.D. Opioidergic modulation of cocaine conditioned place preference. Life Sci. 50:1992;85-90.
8. Bourin M. Cholecystokinin receptor agonists block the jumping behaviour precipitated in morphine-dependent mice by naloxone. Eur. Neuropsychopharmacol. 9:1999;37-43.
9. Dwoskin L.P., Neal B.S., Sparber S.B. Yohimbine exacerbates and clonidine attenuates acute morphine withdrawal in rats. Eur. J. Pharmacol. 90:1983;269-273.
10. El-Kadi A.O., Sharif S.I. The influence of chronic treatment with clonidine, yohimbine and idazoxan on morphine withdrawal. Psychopharmacolog. (Berl.). 132:1997;67-73.
11. Garzón J., Sánchez-Blázquez P. N-acetyl human â-endorphine-(1-31) alleviates the morphine withdrawal syndrome in rodents: a comparative study with clonidine. Life Sci. 50:1992;2099-2109.
12. 2-adrenoceptors play an integral role in the antinociceptive mechganism of action of antidepressant compounds? Eur. J. Pharmacol. 378:1999;161-168.
13. Jiménez-Rivera C.A., Segarra O., Santacana G., Hoffman T., Savage D.D., Weiss G.K. Chronic imipramine treatment induces downregulation of alpa-2 receptors rats locus coeruleus and A2 region of the tractus solitarius. Life Sci. 58:1996;287-294.
14. 2-adrenoceptors. Trends Pharmacol. Sci. 12:1991;62-67.
15. Hughes C.E., Habash T., Dykstra L.A., Picker M.J. Discriminative-stimulus effects of morphine in combination with α and β-noradrenergic agonists and antagonists in rats. Pharmacol. Biochem. Behav. 53:1996;979-986.
16. Iglesias V., Alguacil L.F., Alamo C., Cuenca E. Effects of yohimbine on morphine analgesia and physical dependence in the rat. Eur. J. Pharmacol. 211:1992;35-38.
17. 1-adrenergic up-regulation. J. Neural. Transm. 105:1998;329-342.
18. Maldonado R. Participation of noradrenergic pathways in the expression of opiate withdrawal: biochemical and pharmacological evidence. Neurosci. Biobehav. Rev. 21:1997;91-104.
19. Maldonado R., Stinus L., Koob G.F. Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J. Pharmacol. Exp. Ther. 261:1992;669-677.
20. Redmond D.E. Jr., Krystal J.H. Multiple mechanisms of withdrawal from opioid drugs. Annu. Rev. Neurosci. 7:1984;443-478.
21. Sharif S.I., El Kadi A.O. Modification of naloxone-precipitated withdrawal sympyoms in mice by drugs acting on alpha2-adrenoceptors. Behav. Pharmacol. 7:1996;334-340.
22. Stine S.M., Southwick S.M., Petrakia I.L., Kosten T.R., Charney D.S., Krystal J.H. Yohimbine-induced withdrawal and anxiety symptoms in opioid-dependent patients. Biol. Psychiatry. 51:2002;642-651.
23. 1-adrenoceptor-induced translocation of protein kinase C in the central nervous system in rats. Pharmacol. Res. 35:1997;569-576.
24. Taylor J.R., Lewis J.D., Elsworth E.J., Pivirotto P., Roth R.H., Redmond D.E. Yohimbine co-treatment during chronic morphine administration attenuates naloxone precipitated withdrawal without diminishing tail-flick analgesia in rats. Psychopharmacology. 103:1991;407-414.
25. 2-receptors. Naunyn-Schmiedeberg's. Arch. Pharmacol. 329:1985;293-298.
26. 1-adrenergic properties of B-HT920 revealed in morphine-dependent rats. Pharmacol. Biochem. Behav. 26:1987;265-269.
27. Weis O.F., Sriwatanakul K., Alloza J.L., Weintraub M., Lasagna L. Attitudes of patients, housestaff, and nurses toward postoperative analgesic care. Anesth. Analg. 62:1983;70-74.
28. Zarrindast M.R., Farzin D. Nicotine attenuates naloxone-induced jumping behaviour in morphine-dependent mice. Eur. J. Pharmacol. 298:1996;1-6.
29. Zarrindast M.R., Fazli-Tabaei S., Semnanian S., Fathollahi Y. Influence of different adrenoceptor agonists and antagonists on physostigmine-induced yawning in rats. Pharmacol. Biochem. Behav. 62:1999;1-5.
30. Zarrindast M.R., Fazli-Tabaei S., Semnanian S., Fathollahi Y., Yahyavi S.H. Effects of adrenoceptor agents on apomorphine-induced licking behaviour in rats. Pharmacol. Biochem. Behav. 65:2000;275-279.